Related Experiment Video
Updated: Aug 29, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Diuretics-first line treatment for hypertension?]
1Medizinische Universitäts-Poliklinik, Bonn, Germany. duesing@uni-bonn.de
Insights
Diuretic therapy for hypertension increases new-onset diabetes risk, especially with long-term use. Poor patient compliance further challenges their proposed benefits over newer medications.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Diuretics are commonly used for arterial hypertension treatment.
- Recent studies and economic factors suggest broader initial use of diuretics.
- Controversy exists regarding the long-term efficacy and safety of diuretics.
Purpose of the Study:
- To analyze the incidence of new-onset diabetes with diuretic therapy.
- To evaluate patient compliance and persistence with diuretic medications.
- To challenge the proposed medical and economic benefits of diuretics compared to other antihypertensives.
Main Methods:
- Review of recent studies on diuretic therapy in hypertension.
- Analysis of comparative incidence of new-onset diabetes.
- Assessment of patient compliance and persistence in real-life studies.
Main Results:
- Diuretic therapy is linked to a higher incidence of new-onset diabetes compared to calcium channel blockers, ACE-inhibitors, and AT(1)-antagonists.
- The "numbers needed to treat" (NNT) for diabetes development can be remarkably small (<10) with long-term diuretic use.
- Real-world studies show low patient compliance and persistence with diuretics.
Conclusions:
- The increased risk of new-onset diabetes and poor compliance question the benefits of diuretics.
- Diuretics may not offer the same medical or economic advantages as newer antihypertensive agents.
- Further evaluation is needed to balance the risks and benefits of diuretics in hypertension management.
Study Results:
The role of diuretics in the treatment of arterial hypertension remains a matter of controversy. On the basis of the results of recent studies and economic considerations a broader use of diuretics in the initial antihypertensive therapy has been proposed. The present review analyses two aspects of diuretics which are of interest in this debate. Thus, several studies demonstrate that diuretic therapy is associated with a greater incidence of new-onset diabetes as compared to calcium channel blockers, ACE-inhibitors and AT(1)-antagonists. The clinical relevance of this effect becomes clear when calculating the "numbers needed to treat" (NNT) on the basis of a long-term therapy over several decades. Based on the assumption of linear increases in the incidence of diabetes over time NNT then become remarkably small and in some studies number < 10. Another problem associated with diuretics is the low compliance and persistence with this type of drugs established in "real life" studies in which patients were not disciplined by the study design. These characteristics of diuretic therapy of hypertensive patients challenge the proposed medical and also economic benefit of diuretics as compared to more "modern" antihypertensive agents.
Related Concept Videos
Antihypertensive Drugs: Action of Diuretics
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Thiazide-Class Diuretics
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure V: Medical Management